N@N

Market Maker Surveillance Report. ACUR, DEXO, NSPH, ECTY, GEVO, ONCS, Losing Stocks With Lowest Price Friction For Tuesday, Ju

June 21, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3560 companies with "abnormal" market making, 4305 companies with positive Friction Factors and 1695 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. ACURA PHARMACEUTICALS INC (NASDAQ:ACUR), DEX ONE CORP (NYSE:DEXO), NANOSPHERE INC (NASDAQ:NSPH), ECOTALITY INC (NASDAQ:ECTY), GEVO INC (NASDAQ:GEVO), (OTCBB:ONCS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     ACUR       $-0.420      -9.33%       573,902         47.57%       616,819         51.13%       -42,917         -1,022  
     DEXO       $-0.390      -13.45%      825,862         31.69%       916,598         35.17%       -90,736         -2,327  
     NSPH       $-0.570      -25.68%      1,174,919       39.15%       1,825,680       60.84%       -650,761        -11,417 
     ECTY       $-0.480      -15.69%      181,093         38.49%       289,349         61.51%       -108,256        -2,255  
     GEVO       $-1.340      -9.05%       312,654         14.91%       579,553         27.64%       -266,899        -1,992  
     ONCS       $-0.150      -11.81%      29,224          48.90%       30,538          51.10%       -1,314          -88     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ACUR with a dollar loss Tuesday of $-0.42000 and a Friction Factor of -1,022 shares. That means that it only took 1,022 more shares of selling than buying to move ACUR lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

ACURA PHARMACEUTICALS INC (NASDAQ:ACUR) - Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion Technology, Impede Technology, and other technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, decongestants, and various other opioid analgesics. The companys lead product candidate, Acurox Tablet, is an orally administered immediate release tablet containing oxycodone HCl as its active analgesic ingredient. Its opioid analgesic product candidates are used to relieve pain while discouraging common methods of opioid product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. The company is also investigating and developing mechanisms to incorporate abuse deterrent characteristics into abused and misused pharmaceutical products through laboratory testing of a product candidate developed with its Impede Technology, which is intended to inhibit the conversion of pseudoephedrine HCl into methamphetamine. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize various opioid analgesic products utilizing the companys proprietary Aversion Technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.

DEX ONE CORP (NYSE:DEXO) - Dex One Corporation operates as a marketing solutions company. The company offers various marketing solutions to promote businesses on the Internet, such as assessment of marketing programs and advertisements, message and image creation, recommendations for advertising placement, industry-specific research and information, market-specific research and information, in-depth understanding of how consumers search for businesses and what influences them to buy from one business versus another, Dex published yellow pages, Dex published white pages, search engine optimization strategies, keyword implementation, social strategies, and tracking and reporting. It also provides printed yellow pages directories, including core directories, community directories, and plus companion directories to meet the advertising needs of local and national businesses and the informational needs of local consumers. In addition, the company offers online products and services comprising Dexknows.com, which allows the user to search based on a category, business name, or set of keyword terms within a geographic region, as well as provides users to refine their searches, such as specific product and brand names, hours of operation, payment options, and locations; and DexNet for the placement of clients business listings in prime locations on DexKnows.com. Further, it provides other marketing solutions, such as local business and market analysis, target market identification, advertising and digital profile creation, and distribution strategies. The company was formerly known as R.H. Donnelley Corporation and changed its name to Dex One Corporation in January 2010. Dex One Corporation was founded in 1841 and is headquartered in Cary, North Carolina.

NANOSPHERE INC (NASDAQ:NSPH) - Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology provides the ability to run multiple tests simultaneously on the same sample, as well as simplifies molecular diagnostic testing. The company develops diagnostic tests for markers, which reveal the existence of various medical conditions, including cardiovascular, respiratory, cancer, autoimmune, neurodegenerative, and other infectious diseases, as well as for pharmacogenomics. It also engages in developing and commercializing genomic and protein assays, including hyper-coagulation, warfarin metabolism, cystic fibrosis, respiratory virus panel, hemochromatosis, blood infection panel, cardiac troponin I, connective tissue, prostate specific antigen, and biomarker validation. Nanosphere intends to market its solutions for applications in the hospital-based laboratories and academic research institutions in the United States. The company is headquartered in Northbrook, Illinois.

ECOTALITY INC (NASDAQ:ECTY) - ECOtality, Inc., through its subsidiaries, provides clean electric transportation and storage technologies in the United States and internationally. It offers electric vehicle infrastructure products and solutions that are used in on-road grid-connected vehicles, material handling, and airport electric ground support applications. The company engages in the development, manufacture, assembly, and sale of specialty solar products, battery systems, and hydrogen and fuel cell systems. It provides energy engineering services, such as hydrogen, solar, battery, coal gasification, and energy delivery infrastructure; eTecs Minit-Charger fast-charge systems for material handling and airport ground support equipment; and charging systems for on-road grid-connected electric vehicles. The company also offers eTec bridge power manager systems; hydrogen internal combustion engine vehicle conversions; industrial battery systems; solar panel production; specialty solar solutions; specialty thin-sealed lead battery products; various proprietary solar products for consumer, emergency response programs, and remote power systems; third-party hydrogen and education related products; and EV microclimate programs. In addition, it provides renewable energy solar modules and thin-sealed rechargeable batteries; and Hydrality, a reactor system that stores and delivers hydrogen on-demand using magnesium compounds and water. Further, the company operates an online retail store that provides demonstration kits, educational materials, fuel cell systems, and component parts, as well as offers consulting services for high schools, colleges, and research institutes. It serves commercial, industrial, institutional, governmental, and utility customers. The company was formerly known as Alchemy Enterprises, Ltd. and changed its name to ECOtality, Inc. in November 2006. ECOtality, Inc. was founded in 1999 and is headquartered in Tempe, Arizona.

GEVO INC (NASDAQ:GEVO) - Gevo, Inc., a development stage renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The company develops Gevo Integrated Fermentation Technology, an integrated technology platform for the production and separation of isobutanol. Its products are used as specialty chemicals and fuel blendstocks, as well as could be dehydrated to produce butenes that have various industrial uses in the production of plastics, fibers, rubber, and other polymers. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

(OTCBB:ONCS) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net